ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate

Request For Quotation
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Suppliers list
Company Name: ANHUI WITOP BIOTECH CO., LTD
Tel: +8615255079626
Email: eric@witopchemical.com
Products Intro: Product Name:Tofacitinib Impurity 25
CAS:2227199-31-5
Company Name: ShenZhen H&D Pharmaceutical Technology Co., LTD
Tel: +8618627948422
Email: sale@hdimpurity.com
Products Intro: Product Name:Tofacitinib Impurity 99
CAS:2227199-31-5
Purity:0.98 Package:10mg;|25mg;|50mg
Company Name: Runte International Trade Limited
Tel: 19565631292
Email: lucky@sdruntechem.com
Products Intro: Product Name:butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
CAS:2227199-31-5
Purity:95% HPLC HNMR MS Package:mg;g
Company Name: Sinco Pharmachem (ShenZhen) R&D Co., Ltd.
Tel: +undefined18603013401
Email: jack.lin@sincopharmachem.com
Products Intro: Product Name:Tofacitinib Related Compound 34
CAS:2227199-31-5
Purity:98% HPLC Package:10mg;25mg;50mg;100mg Remarks:COA, 1H NMR, MS, and HPLC purity data provided with shipment.
Company Name: QUALITY CONTROL SOLUTIONS LTD.
Tel: +86-0755-66853366 +86-13670046396
Email: export03@qcsrm.com
Products Intro: Product Name:Tofacitinib Impurity 27
CAS:2227199-31-5
Purity:0.95 Package:10mg; 25mg;50mg;100mg Remarks:Brand: QCS; Can provide COA, hydrogen spectrum, mass spectrometry, liquid phase; Level: Pharmaceutical Impurity Standard

butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate manufacturers
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Basic information
Product Name:butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
Synonyms:Tofacitib related impurities 40;Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate;N-Butyl 3-Oxopropanoate Tofacitinib;Tofatinib Impurity 12;Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity）;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-;Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester
CAS:2227199-31-5
MF:C20H29N5O3
MW:387.47596
EINECS:
Product Categories:
Mol File:2227199-31-5.mol
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Structure
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Chemical Properties
density 1+-.0.06 g/cm3(Predicted)
storage temp. Store at 0-8 °C
pka13.31±0.50(Predicted)
Safety Information
MSDS Information
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Usage And Synthesis
UsesN-Butyl 3-oxopropanoate Tofacitinib is an impurity of Tofacitinib(T528000) which is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Preparation Products And Raw materials
Tag:butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate(2227199-31-5) Related Product Information
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity Tofacitinib Impurity 36 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE Tofacitinib Related Compound Tofacitinib Impurity 45 Tofacitinib Impurity 2